The reason the CUV share price has fallen 25% in just 5 weeks is...

The reason the CUV share price has fallen 25% in just 5 weeks is Short selling which introduces fake liquidity to the market. There is no other reason it is clear and unambiguous as shown by ASIC data. On 11th October the share price closed at $39.52 and open shorts at 3.95%. On 16th November share price closed at $31.96 and open shorts at 4.8%. This 0.85% increase in short selling equates to 420000 fake shares in a tightly held stock - actual volumes have been quite low and only about 1% of real stock would have changed hands. The myth of competition is laughable, Clinuvel has a monopoly. Broker downgrade to HOLD with price UNCHANGED is not the reason. Cash flow report shows the company is growing revenue and profits ~50% and they have clinical trials underway in STROKE and DNA REPAIR/SKIN CANCER fields which are galactic. Short sellers will have to buy back 2.5 Million shares at some point, the board and management of this company also need to put shareholders interests front and centre at some point to deter such manipulative behaviour.